TY - JOUR
T1 - Determination of retinal nerve fibre layer and ganglion cell/inner plexiform layers progression rates using two optical coherence tomography systems
T2 - The PROGRESSA study
AU - Saks, Danit
AU - Schulz, Angela
AU - Craig, Jamie
AU - Graham, Stuart
AU - the PROGRESSA Study Group
PY - 2020/10/12
Y1 - 2020/10/12
N2 - Importance: Glaucoma progression rates may differ depending on the retinal structural parameters measured, and between devices. Background: To compare retinal nerve fibre layer (RNFL) and ganglion cell/inner plexiform layers (GCL/IPL) progression rates using two spectral-domain optical coherence tomography (OCT) systems. Design: Prospective, university hospital setting. Participants: Cross-sectional study: 100 eyes from 53 glaucoma suspects and early manifest glaucoma cases. Longitudinal study: subset of 61 eyes from 33 participants. Methods: Same day optic nerve and macular images were acquired using Cirrus and Spectralis systems from which RNFL and GCL/IPL thicknesses were calculated. Longitudinal analysis of RNFL and GCL/IPL progression rates was calculated from 6 × 6-monthly follow-up OCT scans. Main Outcome Measures: RNFL and GCL/IPL thicknesses in matched superior, inferior and global regions were compared by both systems cross-sectionally and longitudinally. Results: At baseline, no RNFL thicknesses differed between devices. Cirrus GCL/IPL regions were significantly thicker than Spectralis (P <.001). RNFL and GCL/IPL global progression rates (μm/y) had a mean (SD) of −1.28 (1.11) and 95% CI: (−1.48, −1.09) and −0.51 (0.58) and 95% CI: (−0.62, −0.41), respectively. Progression rates were similar across devices. RNFL loss (%) progressed significantly faster than GCL/IPL, in all regions (P ≤.004). Conclusion and Relevance: Despite baseline thickness differences, overall Cirrus and Spectralis provided similar rates of RNFL and GCL/IPL progression in early glaucoma and can be considered comparable, though not interchangeable, in clinical practice. Further analysis is needed to determine if RNFL progresses faster than GCL/IPL in glaucoma, and whether one precedes the other.
AB - Importance: Glaucoma progression rates may differ depending on the retinal structural parameters measured, and between devices. Background: To compare retinal nerve fibre layer (RNFL) and ganglion cell/inner plexiform layers (GCL/IPL) progression rates using two spectral-domain optical coherence tomography (OCT) systems. Design: Prospective, university hospital setting. Participants: Cross-sectional study: 100 eyes from 53 glaucoma suspects and early manifest glaucoma cases. Longitudinal study: subset of 61 eyes from 33 participants. Methods: Same day optic nerve and macular images were acquired using Cirrus and Spectralis systems from which RNFL and GCL/IPL thicknesses were calculated. Longitudinal analysis of RNFL and GCL/IPL progression rates was calculated from 6 × 6-monthly follow-up OCT scans. Main Outcome Measures: RNFL and GCL/IPL thicknesses in matched superior, inferior and global regions were compared by both systems cross-sectionally and longitudinally. Results: At baseline, no RNFL thicknesses differed between devices. Cirrus GCL/IPL regions were significantly thicker than Spectralis (P <.001). RNFL and GCL/IPL global progression rates (μm/y) had a mean (SD) of −1.28 (1.11) and 95% CI: (−1.48, −1.09) and −0.51 (0.58) and 95% CI: (−0.62, −0.41), respectively. Progression rates were similar across devices. RNFL loss (%) progressed significantly faster than GCL/IPL, in all regions (P ≤.004). Conclusion and Relevance: Despite baseline thickness differences, overall Cirrus and Spectralis provided similar rates of RNFL and GCL/IPL progression in early glaucoma and can be considered comparable, though not interchangeable, in clinical practice. Further analysis is needed to determine if RNFL progresses faster than GCL/IPL in glaucoma, and whether one precedes the other.
KW - ganglion cell layer
KW - glaucoma
KW - optical coherence tomography
KW - retinal nerve fibre layer
UR - http://www.scopus.com/inward/record.url?scp=85089397163&partnerID=8YFLogxK
UR - http://purl.org/au-research/grants/NHMRC/1048037
U2 - 10.1111/ceo.13826
DO - 10.1111/ceo.13826
M3 - Article
C2 - 32643824
AN - SCOPUS:85089397163
VL - 48
SP - 915
EP - 926
JO - Clinical and Experimental Ophthlamology
JF - Clinical and Experimental Ophthlamology
SN - 1442-9071
IS - 7
ER -